These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3952737)

  • 1. Histopathology of interscapular brown adipose tissue, thyroid, and pancreas in 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-treated rats.
    Rozman K; Pereira D; Iatropoulos MJ
    Toxicol Appl Pharmacol; 1986 Mar; 82(3):551-9. PubMed ID: 3952737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of a sublethal dose of 2,3,7,8-tetrachlorodibenzo-p-dioxin on interscapular brown adipose tissue of rats.
    Rozman K; Pereira D; Iatropoulos MJ
    Toxicol Pathol; 1987; 15(4):425-30. PubMed ID: 3432942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brown adipose tissue is a target tissue in 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) induced toxicity.
    Rozman K; Strassle B; Iatropoulos MJ
    Arch Toxicol Suppl; 1986; 9():356-60. PubMed ID: 3468916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on thermogenesis in brown adipose tissue of rats.
    Weber LW; Haart TW; Rozman K
    Toxicol Lett; 1987 Dec; 39(2-3):241-8. PubMed ID: 3686553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hexadecane increases the toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD): is brown adipose tissue the primary target in TCDD-induced wasting syndrome?
    Rozman K
    Biochem Biophys Res Commun; 1984 Dec; 125(3):996-1004. PubMed ID: 6517950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue-specific alterations of de novo fatty acid synthesis in 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-treated rats.
    Gorski JR; Weber LW; Rozman K
    Arch Toxicol; 1988; 62(2-3):146-51. PubMed ID: 3196149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Some endocrine and morphological aspects of the acute toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD).
    Gorski JR; Muzi G; Weber LW; Pereira DW; Arceo RJ; Iatropoulos MJ; Rozman K
    Toxicol Pathol; 1988; 16(3):313-20. PubMed ID: 3057589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Han/Wistar rats are exceptionally resistant to TCDD. I.
    Pohjanvirta R; Tuomisto J; Vartiainen T; Rozman K
    Pharmacol Toxicol; 1987 Feb; 60(2):145-50. PubMed ID: 3575248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thyroid hormones modulate the toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD).
    Rozman K; Rozman T; Scheufler E; Pazdernik T; Greim H
    J Toxicol Environ Health; 1985; 16(3-4):481-91. PubMed ID: 4087313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of thyroidectomy and thyroxine on 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) induced toxicity.
    Rozman K; Rozman T; Greim H
    Toxicol Appl Pharmacol; 1984 Feb; 72(2):372-6. PubMed ID: 6695381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NTP technical report on the toxicology and carcinogenesis studies of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) (CAS No. 1746-01-6) in female Harlan Sprague-Dawley rats (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2006 Apr; (521):4-232. PubMed ID: 16835633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue-specific effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on the activity of 5'-deiodinases I and II in rats.
    Viluksela M; Raasmaja A; Lebofsky M; Stahl BU; Rozman KK
    Toxicol Lett; 2004 Mar; 147(2):133-42. PubMed ID: 14757317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship of the wasting syndrome to lethality in rats treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin.
    Christian BJ; Inhorn SL; Peterson RE
    Toxicol Appl Pharmacol; 1986 Feb; 82(2):239-55. PubMed ID: 3945951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased liver type I 5'-deiodinase and increased brown adipose tissue type II 5'-deiodinase activity in 2,3,7,8-tetrachlorobibenzo-p-dioxin (TCDD)-treated Long-Evans rats.
    Raasmaja A; Viluksela M; Rozman KK
    Toxicology; 1996 Dec; 114(3):199-205. PubMed ID: 8980709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypophagia-induced weight loss in mice, rats, and guinea pigs treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin.
    Kelling CK; Christian BJ; Inhorn SL; Peterson RE
    Fundam Appl Toxicol; 1985 Aug; 5(4):700-12. PubMed ID: 4043592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Digestible energy and efficiency of feed utilization in rats treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin.
    Seefeld MD; Peterson RE
    Toxicol Appl Pharmacol; 1984 Jun; 74(2):214-22. PubMed ID: 6740672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Target tissue morphology and serum biochemistry following 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) exposure in a TCDD-susceptible and a TCDD-resistant rat strain.
    Pohjanvirta R; Kulju T; Morselt AF; Tuominen R; Juvonen R; Rozman K; Männistö P; Collan Y; Sainio EL; Tuomisto J
    Fundam Appl Toxicol; 1989 May; 12(4):698-712. PubMed ID: 2744273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morphologic lesions and acute toxicity in rainbow trout (Salmo gairdneri) treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin.
    Spitsbergen JM; Kleeman JM; Peterson RE
    J Toxicol Environ Health; 1988; 23(3):333-58. PubMed ID: 3351981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue-specific effects of 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) on the activity of phosphoenolpyruvate carboxykinase (PEPCK) in rats.
    Viluksela M; Stahl BU; Rozman KK
    Toxicol Appl Pharmacol; 1995 Dec; 135(2):308-15. PubMed ID: 8545841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue distribution and toxicokinetics of 2,3,7,8-tetrachlorodibenzo-p-dioxin in rats after intravenous injection.
    Weber LW; Ernst SW; Stahl BU; Rozman K
    Fundam Appl Toxicol; 1993 Nov; 21(4):523-34. PubMed ID: 8253305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.